{"id":4575,"date":"2026-02-25T21:33:49","date_gmt":"2026-02-25T19:33:49","guid":{"rendered":"https:\/\/www.doktorikool.ee\/?post_type=tribe_events&p=4575"},"modified":"2026-02-25T22:46:33","modified_gmt":"2026-02-25T20:46:33","slug":"seminar-reproduktiivmeditsiinis-mitteinvasiivsete-sunnieelsete-soeluuringute-laiem-perspektiiv","status":"publish","type":"tribe_events","link":"https:\/\/www.doktorikool.ee\/en\/uritused\/seminar-reproduktiivmeditsiinis-mitteinvasiivsete-sunnieelsete-soeluuringute-laiem-perspektiiv\/","title":{"rendered":"Guest lecture in reproductive medicine \u201eExpanding the scope of non-invasive prenatal screening\u201d"},"content":{"rendered":"
\n\t

\n\t\t\n\t\t\t13\/03\t\t<\/span>\n\n\t\t\t\t\t\n\t\t\t\t \t\t\t<\/span>\n\t\t\t\n\t\t\t\t13:15\t\t\t<\/span>\n\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t – \t\t\t\t<\/span>\n\t\t\t\n\t\t\t\t\t\t\t\n\t\t\t\t\t14:45\t\t\t\t<\/span>\n\t\t\t\n\t\t\t\t\t\t<\/p>\n<\/div>\n\n\n\n

\ud83d\udccdRavila 19 \u2013\u00a01006, Tartu<\/strong> and online<\/strong><\/p>\n\n\n\n

Non-invasive prenatal screening has swiftly been implemented as a first or second-tier test for common fetal aneuploidies. It relies analyzing circulating cell-free DNA (cfDNA) from maternal blood. This cfDNA\ncomprises both the maternal and fetal genetic material. Recent research has shown further added value of cfDNA analysis, e.f. in early prediction of actionable pregnancy complications or maternal cancer. This expanding scope of non-invasive prenatal screening promises to transform obstetric care from reactive to preventive, personalized medicine.<\/p>\n\n\n\n

Prof. Joris Vermeesch<\/strong><\/h5><\/div><\/div><\/div>
<\/span><\/div><\/div>
\n

Prof. Joris Vermeesch, Leuven University, Belgium<\/p>\n\n\n\n

\n
\n

Joris R. Vermeesch, Ph.D. Ir, is a professor of Molecular Cytogenetics and genome research, and scientific director of the Genomic Core Facility of KU Leuven.<\/p>\n\n\n\n

https:\/\/belgian-research.eu\/laboratory-for-cytogenetics-and-genome-research-ku-leuven\/<\/span><\/a> His laboratory develops and translates novel genomics methods in preimplantation, prenatal and postnatal diagnosis and more recently, cancer screening. Those developments have led to new approaches for rare disease testing, non-invasive prenatal screening and cancer detection, including advanced methods for cell-free DNA analysis. Prof. Vermeesch has published >320 articles and supervised nearlt 30 PhD students.<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n<\/div>\n<\/div>\n<\/div><\/div><\/div>\n\n\n\n

Register HERE<\/a><\/span><\/strong>. The registration is open until March 13, 2026<\/strong>.<\/p>\n\n\n\n

In case of questions, please turn to Prof. Maris Laan, Institute of Biomedicine and Translational Medicine of Tartu University, maris.laan@ut.ee<\/span><\/a>.<\/p>\n\n\n\n

Estonian Doctoral School for Medical and Health Sciences, Veterinary Medicine.<\/p>\n\n\n\t

\n\t\t
\n\t\t\t